Speaker illustration

Doctor Ian Crozier

Christchurch Hospital, Christchurch (New Zealand)

Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter defibrillator

Event: EHRA 2022

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: News on ICDs

Thumbnail

This platform is supported by

logo Novo Nordisk